(R)-1-(2,3-DIFLUOROPHENYL)ETHAN-1-OL, 95%, 100mg

5-Phenyloxolan-2-one, 98%, 1g

4-[(TERT-BUTOXYCARBONYLAMINO)METHYL]PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 100mg

Orotic acid monohydrate, 95.0%, 100g

(2E)-1-(3-bromophenyl)-3-(2-chlorophenyl)prop-2-en-1-one, 95.0%, 10g

1-(3,5-dimethylphenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

(3-Benzyloxy-4-methoxy-phenyl)-methanol, 97.0%, 10g

4,9-Dibromo-2,7-bis(2-octyldodecyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone, 97%, 1g

1-(4-bromo-3-chlorophenyl)-2,2,2-trifluoroethanone, 100mg

5,6-Bis((4-methoxybenzyl)oxy)isobenzofuran-1,3-dione, 95+%, 250mg

(R)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate, 95.0%, 10g

4-(3-Bromophenyl)pyridine>98.0%(GC)5g

Imidazo[1,2-a]pyrazine, 95.0%, 10g